Biogen Inc.BIIB

Where BIIB's EPS (TTM) sits inside its own 10-year distribution, with the yearly high, low and average.

$249.65+5.60 (+2.29%)Previous close
NASDAQHealthcare

BIIB EPS (TTM): current value, 10-year range and year-by-year history

+23.8%/yr10Y CAGR

BIIB's earnings per share compounded at 23.8%/year over the last 10 years — strong long-term growth.

EPS (TTM) History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
BIIB EPS (TTM) historyBIIB EPS (TTM) from Dec 2023 to Sep 2026: low 5.65, high 150.28, latest 150.28.-5.9236.0277.97119.91161.85Dec 23Jun 24Dec 24Sep 25Mar 26Sep 26med 9.34

BIIB EPS (TTM) by year

Yearly range of BIIB’s eps (ttm) from 2016 to 2026. Over the full period it ranged from $5.65 to $150.28, averaging $19.77.

BIIB EPS (TTM) — yearly low, average, high and year-end values
YearLowAverageHighYear-end
2026$5.65$55.09$150.28$150.28
2025$8.83$10.11$10.99$8.83
2024$7.94$9.55$11.19$11.19
2023$7.98$14.49$21.54$7.98
2022$9.77$16.09$20.93$20.93
2021$10.22$13.04$19.06$10.40
2020$24.45$30.30$34.14$24.45
2019$23.21$27.42$31.47$31.47
2018$13.99$16.29$21.60$21.60
2017$11.91$14.85$16.31$11.91
2016$16.92$16.92$16.92$16.92

Net income divided by diluted shares outstanding, over the trailing twelve months. Watching EPS trend over time reveals whether earnings are growing, stagnant, or deteriorating — and provides the denominator behind P/E.

FormulaNet Income ÷ Diluted Shares Outstanding
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.